Fluoromethyl 4-methylbenzenesulfonate is typically used for the preparation of [18F] F-Labeled Radioligands in the application of PET Imaging agents. It is also empolyed as an electrophilic monofluoromethylating reagent in organic synthesis.
Radiosynthesis of O-[11C]methyl-L-tyrosine and O-[18F]Fluoromethyl-L-tyrosine as potential PET tracers for imaging amino acid transport. 
Improved synthesis of [18F]fluoromethyl tosylate, a convenient reagent for radiofluoromethylations. 
Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging. 
Synthesis of a [18F]fluorobenzothiazole as potential amyloid imaging agent. 
Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): Development of ligands with optimized lipophilicity and binding affinity.
Automated synthesis and purification of [18F]fluoro-[di-deutero] methyl tosylate. 
Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor. 
Re-exploring the N-phenylpicolinamide derivatives to develop mGlu4 ligands with improved affinity and in vitro microsomal stability. 
Identification and in vivo evaluation of a fluorine-18 rolipram analogue, [18F]MNI-617, as a radioligand for PDE4 imaging in mammalian brain. 
11C- and 18F-Labeled Radioligands for P-Glycoprotein Imaging by Positron Emission Tomography.